Brexit drug benefit

SIR – There is another side to supplies of medical drugs to the United Kingdom after Brexit.

The NHS is a unique organisation in the EU and, as a big buyer, negotiates prices and predicted UK supply with drug firms.

But every doctor in the UK is familiar with daily shortages of essential drugs due to Uk-priced drugs being shipped out to the EU, tariff free, when the exchange rate is favourable (as it is now) and there is a profit to be made by a wholesaler or intermediary.

Brexit could restrict this dangerous and unpredictable flow, and so benefit patients and doctors, and keep our drug prices low. Tim Manners Frcophth

Sutton on the Forest, North Yorkshire